Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Narrow-Band Imaging (NBI) Versus Lugol Chromoendoscopy in the Detection of Oesophagus Squamous Cell Carcinoma in High Risk Population: a Randomised Controlled Multicentre Trial

NCT04224896 is registered in ClinicalTrials.gov with Hôpital Edouard Herriot as lead sponsor.

NCT NCT04224896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04224896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Narrow-Band Imaging (NBI) Versus Lugol Chromoendoscopy in the Detection of Oesophagus Squamous Cell Carcinoma in High Risk Population: a Randomised Controlled Multicentre Trial
Lead sponsor
Hôpital Edouard Herriot
Phase
Observational
Overall status
Completed
Start date
March 1, 2011
Completion date
December 31, 2015
Enrollment
335 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

french study